Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing BT-1 and BT-2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This study is a multicenter, double-blind, active-controlled, randomized, parallel clinical trial to evaluate the efficacy and safety of DA-2811 when added to ongoing BT-1 and BT-2 combination therapy in patients with type 2 diabetes who have inadequate glycemic control
Epistemonikos ID: 59fe396d8dae4a61034c102ce0b99780d59b1455
First added on: Nov 21, 2025